(10-250) Beyond Clinical Outcomes: The Operational and Financial Benefits of Insulin Lispro in Hyperkalemia Protocols

Wednesday, December 10, 2025

11:00 AM - 12:00 PM

Location: Bayside A, Level 1

Residency Program: HCA HealthTrust MidAmerica Division
Residency Program Type: PGY2 (Health System Pharmacy Administration and Leadership)
Residency Program Location: Kansas

Co-Author(s): Kevin Welch

Primary Author(s)

Cassandra Van Horn, PharmD

PGY2 HSPAL Resident
HCA MidAmerica Health Trust